alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Independent Auditors' Report



To the Shareholders and Board of Directors
of Smith Barney New Jersey Municipals Fund Inc.:

In planning and performing our audit of the financial statements of the Smith
Barney New Jersey Municipals Fund Inc. (the "Fund") for the year ended March
31, 2001, we considered its internal control, including control activities for
safeguarding securities, in order to determine our auditing procedures for the
purpose of expressing our opinion on the financial statements and to comply
with the requirements of Form N-SAR, not to provide assurance on internal
control.

The management of the Fund is responsible for establishing and maintaining
internal control.  In fulfilling this responsibility, estimates and judgments
by management are required to assess the expected benefits and related costs
of controls.  Generally, controls that are relevant to an audit pertain to the
entity's objective of preparing financial statements for external purposes
that are fairly presented in conformity with accounting principles generally
accepted in the United States of America. Those controls include the
safeguarding of assets against unauthorized acquisition, use, or disposition.

Because of inherent limitations in internal control, error or fraud may occur
and not be detected.  Also, projection of any evaluation of internal control
to future periods is subject to the risk that it may become inadequate because
of changes in conditions or that the effectiveness of the design and operation
may deteriorate.

Our consideration of internal control would not necessarily disclose all
matters in internal control that might be material weaknesses under standards
established by the American Institute of Certified Public Accountants.  A
material weakness is a condition in which the design or operation of one or
more of the internal control components does not reduce to a relatively low
level the risk that misstatements caused by error or fraud in amounts that
would be material in relation to the financial statements being audited may
occur and not be detected within a timely period by employees in the normal
course of performing their assigned functions.  However, we noted no matters
involving internal control and its operation, including controls for
safeguarding securities, that we consider to be material weaknesses as defined
above as of March 31, 2001.

This report is intended solely for the information and use of management, the
Board of Directors of the Fund, and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone other than these
specified parties.




New York, New York
May 8, 2001
Sean M. DONAHUE, Petitioner v. PENNSYLVANIA

No. 19-5808

Supreme Court of the United States.

December 16, 2019

Petition for rehearing denied.
(logo)LNR

          Partners, LLC

 

 

ANNUAL STATEMENT OF COMPLIANCE

 

OF

 

LNR PARTNERS, LLC

 

 

The undersigned, Job Warshaw,being the President of LNR Partners, LLC (the “Special Servicer”), as special servicerunder the applicable Pooling and Servicing Agreement for the transactionslisted on Schedule I hereto, hereby certifies, subject to anylimitations listed on Schedule I hereto, as of the date hereof, onbehalf of the Special Servicer, solely in his capacity as an authorized officerof the Special Servicer and not in his individual capacity, as follows:

 

1.            A review ofthe activities performed by the Special Servicer during the period commencingon January 1, 2018 and ending on December 31, 2018 (or any other shorter periodset forth on Schedule I hereto) (the “'Reporting Period”), and of theSpecial Servicer’s performance under the Pooling and Servicing Agreement hasbeen made under my supervision; and

 

2.            To the bestof my knowledge, based on such review and using the applicable servicingcriteria under Item 1122 of Regulation AB, the Special Servicer has fulfilledall of its obligations under the applicable Pooling and Servicing Agreement inall material respects throughout the Reporting Period.

 

LNR PARTNERS, LLC,

a Florida limited liabilitycompany

 

 

By: /s/ Job Warshaw

Job Warshaw

President

 

 

Dated: February 19, 2019

 

 

1601 Washington Avenue • Suite 700 • Miami Beach,Florida 33139-3164

Telephone: (305) 695-5600 • Fax: (305) 695-5601

 

 

 

**Schedule I**

 

 

MSC 2017-HR2

Morgan Stanley Capital I Trust2017-HR2, Commercial Mortgage Pass-Through Certificates, Series 2017-HR2

 

DBRS, Inc.

333 West Wacker Drive, Suite1800

Attn: Commercial Mortgage Surveillance

Chicago IL 60606

General Contact

 

Fitch Ratings Inc.

33 Whitehall Street

Attention: CommercialMortgaged Surveillance

New York NY 10004

General Contact

 

Moody’s Investors Service,Inc.

7 World Trade Center

250 Greenwich Street

Attn: Commercial MortgageSurveillance Group

New York NY 10007

General Contact

 

Morgan Stanley Capital I Inc.

1221 Avenue of the Americas

New York NY 10020

James Y. Lee

 

Morgan Stanley Capital I Inc.

1585 Broadway

New York NY 10036

Jane Lam

 

Park Bridge Lender ServicesLLC

600 Third Avenue, 40th Floor

Att: MSC 2017-HR2

New York NY 10016

Group

 

Wells Fargo Bank, N.A.

9062 Old Annapolis Road

Columbia MD 21045

Group Notices

 

Wilmington Trust, NationalAssociation

1100 North Market Street

Wilimington DE 19890

Dorri Costello

 

Wilmington Trust, NationalAssociation

1100 North Market Street

Wilmington DE 19890

Group
# C_2018189EN.01001401.xml

| 4.6.2018 | EN | Official Journal of the European Union | C 189/14 |
| --- | --- | --- | --- |

4.6.2018

EN

Official Journal of the European Union

C 189/14

---

Non-opposition to a notified concentration

(Case M.8899 — OTPP/Carlyle/European Camping Group)

(Text with EEA relevance)

(2018/C 189/02)

On 24 May 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8899. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8899. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
# C_2018248EN.01000301.xml

| 16.7.2018 | EN | Official Journal of the European Union | C 248/3 |
| --- | --- | --- | --- |

16.7.2018

EN

Official Journal of the European Union

C 248/3

---

Special Report No 18/2018

‘Is the main objective of the preventive arm of the Stability and Growth Pact delivered?’

(2018/C 248/03)

The European Court of Auditors hereby informs you that Special Report No 18/2018 ‘Is the main objective of the preventive arm of the Stability and Growth Pact delivered?’ has just been published.

The report can be accessed for consultation or downloading on the European Court of Auditors' website: http://eca.europa.eu

---
Jerel Leon JORDAN, Petitioner, v. UNITED STATES.

No. 19-5676

Supreme Court of the United States.

Nov. 25, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

ZEV ABRAHAM LENCHUS,

Appellant,

v.

ANNA YAROVICH LENCHUS,

Appellee.

No. 4D22-1774

[August 10, 2023]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Linda A. Alley, Judge; L.T. Case No. FMCE21015183.

Laura Davis Smith and Sonja A. Jean of Davis Smith & Jean, LLC, 

Coral Gables, for appellant.

Darius Asly, Miami Beach, for appellee.

PER CURIAM.

Affirmed.

KLINGENSMITH, C.J., CONNER and FORST, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Exhibit 10.17

 

AMENDMENT TO

DONALD E. STOUT’S MEMBERSHIP TO

THE BOARD OF DIRECTORS

OF AUGME TECHNOLOGIES, INC.

 

The Agreement dated January 4, 2011 between Donald E. Stout and Augme Technologies, Inc. (“Augme” or the “Company”) is hereby amended:

 

Original Agreement:

 

The Board also approved the following compensation package:

 

You will receive a stock option grant of 300,000 unregistered options of common stock of the Company at an exercise price of $2.85 (which exercise price is not less than the closing price for the Company stock on the date of the Board approval of your appointment to the Board (January 4, 2010)), which options will vest 1/36 per month with a term of a five (5) years, per the terms and conditions of the Company’s standard stock option agreement (which agreement includes accelerated (100%) vesting upon a Change in Control of the Company).  In addition, you will receive a quarterly stock option grant, commencing with the Company’s fiscal fourth quarter ending February 28, 2011, equal to six-thousand (6,000) options per quarter in which you are a member of the Board on the last day of the quarter, which options (a) shall have an exercise price equal to the 20-day trailing average closing price of the stock (from the last day of the quarter) with respect to the quarter of which the grant relates; and (b) shall have the same vesting period and term as described above.

 

Replaced with:

 

The Board also approved the following compensation package:

 

You will receive a stock option grant of 300,000 unregistered options of common stock of the Company at an exercise price of $2.85 (which exercise price is not less than the closing price for the Company stock on the date of the Board approval of your appointment to the Board (January 4, 2010)), which options will vest 1/36 per month, over a three year period, with a term of a five (5) years, per the terms and conditions of the Company’s standard stock option agreement (which agreement includes accelerated (100%) vesting upon a Change in Control of the Company).  In addition, you will receive a quarterly stock option grant, commencing with the Company’s fiscal fourth quarter ending February 28, 2011, equal to six-thousand (6,000) options per quarter in which you are a member of the Board on the last day of the quarter, which options (a) shall have an exercise price equal to the 10-day trading days before the last day of each fiscal quarter which the grant relates; and (b) shall have the same vesting period and term as described above.

 

[SIGNATURES ON FOLLOWING PAGE]

 











 

IN WITTNESS WHEREOF, the parties have executed this Amendment to Donald E. Stout’s Membership to the Board of Directors of Augme Technologies, Inc. as of March 16, 2011.

 

 

	
ACCEPTED   BY:
    	
ACCEPTED   BY:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Name:   Shelly Meyers
    	
 
    	
Name:   Donald E. Stout
    
	
 
    	
 
    	
 
    
	
Title:   Chairwoman
    	
 
    	
Title:   Director
```
  
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 04/09/13          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      438,715
COMMITMENTS
 123,754  193,407   68,574  218,923  146,130  411,251  408,111   27,464   30,604

CHANGES FROM 04/02/13 (CHANGE IN OPEN INTEREST:     19,591)
  -2,964   -1,584      232   21,255   20,904   18,523   19,552    1,068       39

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    28.2     44.1     15.6     49.9     33.3     93.7     93.0      6.3      7.0

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      176)
      53       68       79       36       34      142      143
```

----

Updated April 17, 2013
Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Opinion Research Corporation (the Company) on Form 10-Q for the period ended June 30, 2006,
as filed with the Securities and Exchange Commission on the date hereof (the Report), I, John F. Short, Chairman and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.



|                      |  |  |  |         |  |                   |  |                                     
|--------------------- |  |  |  | ------- |  | ----------------- |  | ------------------------------------
|                      |  |  | 
|Date: August 14, 2006 |  |  |  | Signed: |  | /s/ John F. Short
|                      |  |  |  |         |  | Name:             |  | John F. Short                       
|                      |  |  |  |         |  | Title:            |  | Chairman and Chief Executive Officer
CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002







In connection with the amended quarterly report of STAT Software, Inc. (the "Company") on Form 10-QSB/A for the three months ended September 30, 2004, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Douglas P. Condie, acting in the capacity as the Chief Executive Officer of the Company, and I, Richard B. Vincent, acting in the capacity as the Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Douglas P. Condie

Douglas P. Condie

Chief Executive Officer

May 2, 2005





/s/ Richard B. Vincent

Richard B. Vincent

Chief Financial Officer

May 2, 2005
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1181 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 1181

To reduce the annual rate of pay of Members of Congress by 8.2 percent.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 14, 2013

  Mr. DeSantis (for himself, Mr. Bera of California, Mr. Salmon, Mr. 
  Amash, and Mr. Pittenger) introduced the following bill; which was 
 referred to the Committee on House Administration, and in addition to 
 the Committee on Oversight and Government Reform, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
To reduce the annual rate of pay of Members of Congress by 8.2 percent.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sequestration of Pay for Members of 
Congress Act of 2013''.

SEC. 2. REDUCTION IN PAY FOR MEMBERS OF CONGRESS.

    (a) Reduction in Annual Rate.--Notwithstanding any other provision 
of law, the annual rate of pay for each Member of Congress for pay 
periods occurring after the date of the regularly scheduled general 
election for Federal office held in November 2014 shall be equal to the 
applicable rate in effect for the most recent pay period occurring 
prior to such date, reduced by 8.2 percent.
    (b) Member of Congress Defined.--For purposes of this Act, the term 
``Member of Congress'' means an individual serving in a position under 
subparagraph (A), (B), or (C) of section 601(a)(1) of the Legislative 
Reorganization Act of 1946 (2 U.S.C. 31(1)).
                                 <all>
```
Willie MOORE, Petitioner v. Christopher M. CARR, Attorney General of Georgia

No. 19M63

Supreme Court of the United States.

November 18, 2019

Motion to direct the Clerk to file a petition for writ of certiorari out of time denied.
```

[Federal Register Volume 87, Number 114 (Tuesday, June 14, 2022)]
[Notices]
[Page 35967]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12788]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[S-91-2022]

Foreign-Trade Zone 168--Dallas, Texas; Application for Expansion 
of Subzone 168G; Sager Electronics, Carrollton, Texas

    An application has been submitted to the Foreign-Trade Zones (FTZ) 
Board by the Metroplex International Trade Development Corporation, 
grantee of FTZ 168, requesting expanded subzone status for the 
facilities of Sager Electronics located in Carrollton, Texas. The 
application was submitted pursuant to the provisions of the Foreign-
Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the regulations of 
the FTZ Board (15 CFR part 400). It was formally docketed on June 8, 
2022.
    Subzone 168G was approved on November 16, 2020 (S-163-2013, 85 FR 
73674, November 19, 2020). The subzone currently consists of the 
following site: Site 1 (1.46 acres)--2940 Eisenhower Street, Suite 100, 
Carrollton.
    The applicant is requesting authority to expand the subzone to 
include an additional site: Proposed Site 2 (4.03 acres)--2521 Oakbend 
Drive, Lewisville. No authorization for production activity has been 
requested at this time. The proposed expanded subzone would be subject 
to the existing activation limit of FTZ 168.
    In accordance with the FTZ Board's regulations, Camille Evans of 
the FTZ Staff is designated examiner to review the application and make 
recommendations to the Executive Secretary.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is July 25, 2022. 
Rebuttal comments in response to material submitted during the 
foregoing period may be submitted during the subsequent 15-day period 
to August 8, 2022.
    A copy of the application will be available for public inspection 
in the ``Online FTZ Information Section'' section of the FTZ Board's 
website, which is accessible via www.trade.gov/ftz.
    For further information, contact Camille Evans at 
[email protected].

    Dated: June 8, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-12788 Filed 6-13-22; 8:45 am]
BILLING CODE 3510-DS-P
```
David KIRKLAND, Petitioner, v. UNITED STATES.

No. 19-5874

Supreme Court of the United States.

October 15, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
- 1 -

No. 6:24-cv-00019

Christopher Peoples,

Plaintiff,

v.

Drug Enforcement Agency et al.,

Defendants.

ORDER

Plaintiff Christopher Peoples, an inmate of the Cherokee 

County Jail, filed this civil rights lawsuit pro se and in forma pauperis. The case was referred to United States Magistrate Judge 

John D. Love pursuant to 28 U.S.C. § 636(b). Doc. 3. 

On September 4, 2024, the magistrate judge issued a report 

recommending that plaintiff’s motion for a preliminary injunction be denied. Doc. 43. A copy of the report was mailed to the 

plaintiff, who received it on September 10, 2024, and did not file 

written objections. Doc. 44; see Doc. 48 at 1 (“Plaintiff did not 

contest the Court’s disposition of said motion . . . .” (citing Doc. 

43)). 

When no party objects to the magistrate judge’s report and 

recommendation, the court reviews it only for clear error. See 

Douglass v. United Servs. Auto. Ass’n, 79 F.3d 1415, 1420 (5th Cir. 

1996). Having reviewed the magistrate judge’s report, and being 

satisfied that it contains no clear error, the court accepts its findings and recommendation. Plaintiff’s motion for preliminary injunction (Doc. 18) is denied.

So ordered by the court on October 28, 2024.

J. CAMPBELL BARKER

United States District Judge

Case 6:24-cv-00019-JCB-JDL Document 49 Filed 10/28/24 Page 1 of 1 PageID #: 235
Exhibit
32.2




CERTIFICATION




In
connection with the accompanying Quarterly Report on Form 10-Q of PROLOR
Biotech, Inc. for the three months ended March 31, 2010 (the “Report”), the
undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my
knowledge and belief, that:




(1)
            the
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and




(2)
            the
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of PROLOR
      Biotech, Inc.




/s/ Steve SchaefferSteve
      SchaefferPrincipal
      Financial OfficerPROLOR
      Biotech, Inc.


May 14,
2010





The
certification set forth above is being furnished as an Exhibit solely pursuant
to Section 906 of the Sarbanes—Oxley Act of 2002 and is not being filed as part
of the Report or as a separate disclosure document of PROLOR Biotech, Inc. or
the certifying officers.